However, while large numbers of CD8+ T cells can be found in some types of tumors, tumor progression often still persists; in these cases inhibitory mechanisms such as the immunosuppressive CD8+ T cell receptors, PD-1, and CTLA-4 as well as tumor-expressed PD-L1 are often involved. Here, CD8A is linked to neoplasm.